The Fontan Udenafil Exercise Longitudinal Trial: Subgroup Analysis.
Exercise
Fontan
Udenafil
Journal
Pediatric cardiology
ISSN: 1432-1971
Titre abrégé: Pediatr Cardiol
Pays: United States
ID NLM: 8003849
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
01
03
2023
accepted:
31
05
2023
medline:
26
9
2023
pubmed:
29
6
2023
entrez:
29
6
2023
Statut:
ppublish
Résumé
The Pediatric Heart Network's Fontan Udenafil Exercise Longitudinal (FUEL) Trial (Mezzion Pharma Co. Ltd., NCT02741115) demonstrated improvements in some measures of exercise capacity and in the myocardial performance index following 6 months of treatment with udenafil (87.5 mg twice daily). In this post hoc analysis, we evaluate whether subgroups within the population experienced a differential effect on exercise performance in response to treatment. The effect of udenafil on exercise was evaluated within subgroups defined by baseline characteristics, including peak oxygen consumption (VO
Identifiants
pubmed: 37382636
doi: 10.1007/s00246-023-03204-y
pii: 10.1007/s00246-023-03204-y
doi:
Substances chimiques
udenafil
L5IB4XLY36
Sulfonamides
0
Pyrimidines
0
Banques de données
ClinicalTrials.gov
['NCT0274115']
Types de publication
Randomized Controlled Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1691-1701Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Fontan F, Baudet E (1971) Surgical repair of tricuspid atresia. Thorax 26:240–248
doi: 10.1136/thx.26.3.240
pubmed: 5089489
pmcid: 1019078
Kreutzer G, Galindez E, Bono H, De Palma C, Laura JP (1973) An operation for the correction of tricuspid atresia. J Thorac Cardiovasc Surg 66:613–621
doi: 10.1016/S0022-5223(19)40598-9
pubmed: 4518787
Downing TE, Allen KY, Glatz AC, Rogers LS, Ravishankar C, Rychik J, Faerber JA, Fuller S, Montenegro LM, Steven JM, Spray TL, Nicolson SC, Gaynor JW, Goldberg DJ (2017) Long-term survival after the Fontan operation: twenty years of experience at a single center. J Thorac Cardiovasc Surg 154:243-253 e2
doi: 10.1016/j.jtcvs.2017.01.056
pubmed: 28341469
Downing TE, Allen KY, Goldberg DJ, Rogers LS, Ravishankar C, Rychik J, Fuller S, Montenegro LM, Steven JM, Gillespie MJ, Rome JJ, Spray TL, Nicolson SC, Gaynor JW, Glatz AC (2017) Surgical and catheter-based reinterventions are common in long-term survivors of the fontan operation. Circ Cardiovasc Interv. https://doi.org/10.1161/CIRCINTERVENTIONS.116.004924
doi: 10.1161/CIRCINTERVENTIONS.116.004924
pubmed: 28851719
Rogers LS, Glatz AC, Ravishankar C, Spray TL, Nicolson SC, Rychik J, Rush CH, Gaynor JW, Goldberg DJ (2012) 18 years of the Fontan operation at a single institution: results from 771 consecutive patients. J Am Coll Cardiol 60:1018–1025
doi: 10.1016/j.jacc.2012.05.010
pubmed: 22818071
Rychik J (2016) The Relentless Effects of the Fontan Paradox. Semin Thorac Cardiovasc Surg 19:37–43
doi: 10.1053/j.pcsu.2015.11.006
Cunningham JW, Nathan AS, Rhodes J, Shafer K, Landzberg MJ, Opotowsky AR (2017) Decline in peak oxygen consumption over time predicts death or transplantation in adults with a Fontan circulation. Am Heart J 189:184–192
doi: 10.1016/j.ahj.2017.04.009
pubmed: 28625375
Diller GP, Dimopoulos K, Okonko D, Li W, Babu-Narayan SV, Broberg CS, Johansson B, Bouzas B, Mullen MJ, Poole-Wilson PA, Francis DP, Gatzoulis MA (2005) Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation 112:828–835
doi: 10.1161/CIRCULATIONAHA.104.529800
pubmed: 16061735
Diller GP, Giardini A, Dimopoulos K, Gargiulo G, Muller J, Derrick G, Giannakoulas G, Khambadkone S, Lammers AE, Picchio FM, Gatzoulis MA, Hager A (2010) Predictors of morbidity and mortality in contemporary Fontan patients: results from a multicenter study including cardiopulmonary exercise testing in 321 patients. Eur Heart J 31:3073–3083
doi: 10.1093/eurheartj/ehq356
pubmed: 20929979
Fernandes SM, McElhinney DB, Khairy P, Graham DA, Landzberg MJ, Rhodes J (2010) Serial cardiopulmonary exercise testing in patients with previous Fontan surgery. Pediatr Cardiol 31:175–180
doi: 10.1007/s00246-009-9580-5
pubmed: 19915891
pmcid: 4235332
Giardini A, Hager A, Pace Napoleone C, Picchio FM (2008) Natural history of exercise capacity after the Fontan operation: a longitudinal study. Ann Thorac Surg 85:818–821
doi: 10.1016/j.athoracsur.2007.11.009
pubmed: 18291148
Goldberg DJ, Zak V, McCrindle BW, Ni H, Gongwer R, Rhodes J, Garofano RP, Kaltman JR, Lambert LM, Mahony L, Margossian R, Spector ZZ, Williams RV, Atz AM, Paridon SM, Pediatric Heart Network I (2021) Exercise capacity and predictors of performance after Fontan: results from the pediatric heart network Fontan 3 Study. Pediatr Cardiol 42:158–168
doi: 10.1007/s00246-020-02465-1
pubmed: 32975603
Illinger V, Materna O, Slaby K, Jicinska D, Kovanda J, Koubsky K, Pokorny J, Prochazka M, Antonova P, Hoskovec A, Radvansky J, Chaloupecky V, Janousek J (2022) Exercise capacity after total cavopulmonary anastomosis: a longitudinal paediatric and adult study. ESC Heart Fail 9:337–344
doi: 10.1002/ehf2.13747
pubmed: 34894102
Egbe AC, Driscoll DJ, Khan AR, Said SS, Akintoye E, Berganza FM, Connolly HM (2017) Cardiopulmonary exercise test in adults with prior Fontan operation: the prognostic value of serial testing. Int J Cardiol 235:6–10
doi: 10.1016/j.ijcard.2017.02.140
pubmed: 28284501
Goldberg DJ, Paridon SM (2014) Fontan circulation: the search for targeted therapy. Circulation 130:1999–2001
doi: 10.1161/CIRCULATIONAHA.114.013365
pubmed: 25446056
Goldberg DJ, Zak V, Goldstein BH, McCrindle BW, Menon SC, Schumacher KR, Payne RM, Rhodes J, McHugh KE, Penny DJ, Trachtenberg F, Hamstra MS, Richmond ME, Frommelt PC, Files MD, Yeager JL, Pemberton VL, Stylianou MP, Pearson GD, Paridon SM, Pediatric Heart Network I (2018) Design and rationale of the Fontan Udenafil Exercise Longitudinal (FUEL) trial. Am Heart J 201:1–8
doi: 10.1016/j.ahj.2018.03.015
pubmed: 29910047
pmcid: 6010060
Goldberg DJ, Zak V, Goldstein BH, Schumacher KR, Rhodes J, Penny DJ, Petit CJ, Ginde S, Menon SC, Kim SH, Kim GB, Nowlen TT, DiMaria MV, Frischhertz BP, Wagner JB, McHugh KE, McCrindle BW, Shillingford AJ, Sabati AA, Yetman AT, John AS, Richmond ME, Files MD, Payne RM, Mackie AS, Davis CK, Shahanavaz S, Hill KD, Garg R, Jacobs JP, Hamstra MS, Woyciechowski S, Rathge KA, McBride MG, Frommelt PC, Russell MW, Urbina EM, Yeager JL, Pemberton VL, Stylianou MP, Pearson GD (2020) Paridon SM and pediatric heart network I. Results of the FUEL trial. Circulation 141:641–651
doi: 10.1161/CIRCULATIONAHA.119.044352
pubmed: 31736357
Goldberg DJ, French B, McBride MG, Marino BS, Mirarchi N, Hanna BD, Wernovsky G, Paridon SM, Rychik J (2011) Impact of oral sildenafil on exercise performance in children and young adults after the fontan operation: a randomized, double-blind, placebo-controlled, crossover trial. Circulation 123:1185–1193
doi: 10.1161/CIRCULATIONAHA.110.981746
pubmed: 21382896
pmcid: 3073351
Hebert A, Mikkelsen UR, Thilen U, Idorn L, Jensen AS, Nagy E, Hanseus K, Sorensen KE, Sondergaard L (2014) Bosentan improves exercise capacity in adolescents and adults after Fontan operation: the TEMPO (Treatment With Endothelin Receptor Antagonist in Fontan Patients, a Randomized, Placebo-Controlled, Double-Blind Study Measuring Peak Oxygen Consumption) study. Circulation 130:2021–2030
doi: 10.1161/CIRCULATIONAHA.113.008441
pubmed: 25446057
Rychik J, Goldberg DJ, Rand E, Mancilla EE, Heimall J, Seivert N, Campbell D, O’Malley S, Dodds KM (2022) A path FORWARD: development of a comprehensive multidisciplinary clinic to create health and wellness for the child and adolescent with a Fontan circulation. Pediatr Cardiol 43:1175–1192
doi: 10.1007/s00246-022-02930-z
pubmed: 35604474
pmcid: 9125546
Lam CZ, Gulamhusein A, Wald RM (2021) Liver cirrhosis and hepatocellular carcinoma after the Fontan operation: reaching clarity in the face of uncertainty. Circulation 144:1977–1980
doi: 10.1161/CIRCULATIONAHA.121.057431
pubmed: 34928704
Mackie AS, Veldtman GR, Thorup L, Hjortdal VE, Dori Y (2022) Plastic bronchitis and protein-losing enteropathy in the fontan patient: evolving understanding and emerging therapies. Can J Cardiol 38:988–1001
doi: 10.1016/j.cjca.2022.03.011
pubmed: 35314335
Rathgeber SL, Lam C, Harris KC, Grewal J (2022) Hepatic and renal consequences of single-ventricle physiology palliated with the Fontan operation. Can J Cardiol 38:1002–1011
doi: 10.1016/j.cjca.2022.04.022
pubmed: 35525398
Sharma S, Ruebner RL, Furth SL, Dodds KM, Rychik J, Goldberg DJ (2016) Assessment of kidney function in survivors following Fontan palliation. Congenit Heart Dis 11:630–636
doi: 10.1111/chd.12358
pubmed: 27106111
Giardini A, Specchia S, Tacy TA, Coutsoumbas G, Gargiulo G, Donti A, Formigari R, Bonvicini M, Picchio FM (2007) Usefulness of cardiopulmonary exercise to predict long-term prognosis in adults with repaired tetralogy of Fallot. Am J Cardiol 99:1462–1467
doi: 10.1016/j.amjcard.2006.12.076
pubmed: 17493481